FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease

TUESDAY, Oct. 1, 2024-- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic...